Resiniferatoxin
- Generic Name
- Resiniferatoxin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C37H40O9
- CAS Number
- 57444-62-9
- Unique Ingredient Identifier
- A5O6P1UL4I
- Background
Resiniferatoxin (RTX) is a naturally occurring, ultrapotent capsaicin analog that activates the vanilloid receptor in a subpopulation of primary afferent sensory neurons involved in nociception (the transmission of physiological pain).
- Indication
Investigated for use/treatment in interstitial cystitis and urinary incontinence.
- Associated Conditions
- -
- Associated Therapies
- -
Musculoskeletal Pain Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals
The Musculoskeletal Pain Market report highlights key companies and emerging drugs, with the US leading in market size. It covers treatment practices, market trends from 2020 to 2034, and the impact of chronic musculoskeletal pain globally.
Musculoskeletal Pain Treatment Market 2034: Clinical Trials
The Musculoskeletal Pain Treatment Market report by DelveInsight forecasts growth from 2020 to 2034, highlighting key companies, therapies, and market dynamics. It emphasizes the U.S. market size, prevalent cases, and emerging treatments for chronic pain, aiming to address unmet needs and improve patient quality of life.
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Grünenthal enrolls first participants in Phase I trial for NOP receptor agonist, aiming to demonstrate safety and pharmacokinetic characteristics. The trial targets chronic pain relief with improved safety profile compared to opioids.
Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer
Grünenthal's resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee. The non-opioid therapy is in Phase III development.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath